Alcon Aksje

Alcon ROIC

Avkastning på investert kapital (ROIC) av Alcon (ALC.SW) per 24. aug. 2026 er 3,61 %. Forrige år var Avkastning på investert kapital (ROIC) 3,65 % — en endring på −1,26% (lavere).

ROIC

3,61 %

YoY

−1,26%

Sist oppdatert:

Avkastning på investert kapital (ROIC) av Alcon er 2026 3,61 % . Avkastning på investert kapital (ROIC) av Alcon var 2025 3,65 % . Den faller med −1,26% lavere sammenlignet med året før.

Alcon ROIC historikk

  • 3 år

  • 10 år

  • 25 år

  • Maks

ROIC
Date
ROIC
1. jan. 2018
−1,60 USD
1. jan. 2019
−2,74 USD
1. jan. 2020
−2,18 USD
1. jan. 2021
1,52 USD
1. jan. 2022
1,29 USD
1. jan. 2023
3,62 USD
1. jan. 2024
3,65 USD
1. jan. 2025
3,61 USD
Alcon ROIC historikk
ÅRROICYoY
3,61 %−1,26%
3,65 %+1,03%
3,62 %+179,64%
1,29 %−14,84%
1,52 %−169,63%
−2,18 %−20,29%
−2,74 %+70,90%
−1,60 %−245,12%
1,10 %−249,29%
−0,74 %−156,69%
1,30 %
Access this data via the Eulerpool API

Alcon Aksjeanalyse

Hva gjør Alcon? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon er et av de mest populære selskapene på Eulerpool.

Ofte stilte spørsmål om Alcon aksje

Avkastning på investert kapital (ROIC) for Alcon er 3,61 % i 2026.

Avkastning på investert kapital (ROIC) av Alcon endret seg fra 3,65 % til 3,61 %, som representerer en −1,26% endring. Verdien er lavere enn forrige år.

På Eulerpool finner du den komplette historiske utviklingen av Avkastning på investert kapital (ROIC) Alcon siden 2006 – med årlige verdier, diagrammer og detaljert analyse.

ROIC måler hvor effektivt et selskap bruker sitt investerte kapital til å generere fortjeneste. En ROIC over kapitalkostnaden skaper aksjonærverdi.

ROIC = NOPAT / Investert kapital

En «god» varierer etter industri og selskapets utviklingsstadium. På Eulerpool kan du sammenligne Avkastning på investert kapital (ROIC)s Alcon med sektorkolleger og bransjegjennomsnittet for å vurdere om den er attraktiv.

For å evaluere Avkastning på investert kapital (ROIC)s er det viktig å sammenligne det med konkurrenter i samme industri og sektor. På Eulerpool kan du finne direkte bransjesammenlikninger for Avkastning på investert kapital (ROIC).

Access this data via the Eulerpool API

Lønnsomhet — Alcon

Alle nøkkeltall — Alcon